跳至主要内容
临床试验/CTRI/2025/02/080145
CTRI/2025/02/080145尚未招募不适用

Randomized controlled clinical trial to evaluate the role of aaragwadha patra taila in garbhini kikwisa w.s.r.to striae gravidarum

Matoshree Asarabai Darade College Babhulgoan Yeola1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年2月17日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
1.Kandu (Itching)

研究概览

简要总结

Kikwisa is seen in 70 -90 %11 of all Garbhini patients attending in

Streeroga and Prasutitantra OPD. It is the major problem of modern

cosmatic conscious era. So, it requires medical treatment which is cost

effective and with less side effects .

Aaragwadha patra Kalka is mention in Vaidya Manorama and

Karveerpatra siddha taila is mention in Charaka samhita and Asthang

Hridaya for the management

of Garbhini kikwisa. By taking these drugs I

am going to prepare Taila which is easy to apply and it is cost effective

and all drugs to be used in it are easily available.

So, present study is to evaluate the role of Aaragwadha patra taila in

Garbhini kikwisa being proposed.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 30.00 Year(s)(—)
性别
Female

入选标准

  • i)Patients willingly participating in the trial and giving consent form.
  • ii)Primi gravidae patients will be selected for study.
  • iii) Patients with gestational age of 7 th month onward up to delivery.
  • Iv) Patients having classical sign and symptoms of Garbhini kikwisa as per prepared Performa will be selected.

排除标准

  • i)Multi-gravida ii) Diabetic mother.
  • iii) Patients not willing to participate in the trial.
  • iv) Any malignancy on the affected part v) Patients having skin disease.

结局指标

主要结局

1.Kandu (Itching)

时间窗: First day,30th day,60th day,90th day,120th day

2.Vidaha (Burning sensation)

时间窗: First day,30th day,60th day,90th day,120th day

3.Vali vishesh (Strech mark)

时间窗: First day,30th day,60th day,90th day,120th day

4.Vaivarnyata (Discolouration)

时间窗: First day,30th day,60th day,90th day,120th day

all symptoms will be decreased

时间窗: First day,30th day,60th day,90th day,120th day

次要结局

  • Above all symptoms will be decreased(4 months)

研究者

发起方
Matoshree Asarabai Darade College Babhulgoan Yeola
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Shital Dnyanoba More

Matoshree Asarabai Darade Ayurved College Babhulgoan ,Yeola

研究点 (1)

Loading locations...

相似试验